Henry J. Fuchs - Mar 15, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
President, Worldwide R&D
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Mar 15, 2022
Transactions value $
-$1,129,492
Form type
4
Date filed
3/17/2022, 09:47 PM
Previous filing
Mar 10, 2022
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +38.8K +32.51% $0.00 158K Mar 15, 2022 Direct F1
transaction BMRN Common Stock Tax liability -$947K -12.1K -7.65% $78.27 146K Mar 15, 2022 Direct
transaction BMRN Common Stock Tax liability -$182K -2.26K -1.55% $80.72 144K Mar 16, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Award $0 +35.8K $0.00 35.8K Mar 15, 2022 Common Stock 35.8K $78.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on March 15, 2022. Price not applicable.
F2 Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter.